p21 (CDKN1A)-activated kinase 2 |
PAK2 |
ErbB signaling |
0.261 |
p21 (CDKN1A)-activated kinase 2 |
PAK2 |
ErbB signaling |
−0.319 |
PTK2 protein tyrosine kinase 2 |
PTK2 |
ErbB signaling |
−0.152 |
PTK2 protein tyrosine kinase 2 |
PTK2 |
ErbB signaling |
−0.109 |
mitogen-activated protein kinase 9 |
MAPK9 |
ErbB signaling |
0.044 |
v-myc myelocytomatosis viral oncogene homolog |
MYC |
ErbB signaling |
0.109 |
v-myc myelocytomatosis viral oncogene homolog |
MYC |
ErbB signaling |
0.247 |
v-raf murine sarcoma viral oncogene homolog B1 |
BRAF |
ErbB signaling |
0.087 |
B-cell CLL/lymphoma 2 |
BCL2 |
ErbB signaling |
0.240 |
B-cell CLL/lymphoma 2 |
BCL2 |
ErbB signaling |
0.094 |
Hs.170501 |
|
Cancer Gene I |
0.172 |
Hs.73792 (3d/Epstein Barr virus) receptor 2 |
CR2 |
Cancer Gene I |
−0.025 |
Hs.85155 zinc finger protein 36, C3H type-like 1 |
ZFP36L1 |
Cancer Gene I |
−0.041 |
major histocompatibility complex, class II, DM beta |
|
Cancer Gene I |
−0.111 |
major histocompatibility complex, class II, DR alpha |
|
Cancer Gene I |
−0.253 |